InvestmentJun 29, 2026, 04:22 PM
FibroBiologics Raises $3.0M in Private Placement
AI Summary
FibroBiologics, Inc. announced the closing of a private placement offering, generating $3.0 million in gross proceeds. The offering included pre-funded warrants and common stock warrants, with the potential to raise an additional $6.0 million if all warrants are exercised. The net proceeds of approximately $2.6 million from the initial closing will be used for working capital and general corporate purposes. H.C. Wainwright & Co. served as the exclusive placement agent for the transaction.
Key Highlights
- Received $3.0 million in gross proceeds from a private placement offering.
- Potential for an additional $6.0 million in gross proceeds if warrants are fully exercised.
- Issued pre-funded warrants and common stock warrants for up to 4,081,633 shares each.
- Purchase price for shares/warrants was $0.735 per share.
- Net proceeds from the initial offering were approximately $2.6 million.
- H.C. Wainwright & Co. acted as placement agent, receiving 8.0% cash fees and $50,000 for legal fees.
- Placement agent also received warrants to purchase up to 285,714 shares at $0.9188.
Price Impact
More from FBLG